Concepts (312)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Papillomavirus Infections | 37 | 2023 | 336 | 10.220 |
Why?
|
| Puerto Rico | 95 | 2024 | 1378 | 5.910 |
Why?
|
| Anus Neoplasms | 11 | 2023 | 49 | 5.260 |
Why?
|
| Uterine Cervical Neoplasms | 14 | 2021 | 277 | 4.380 |
Why?
|
| Alphapapillomavirus | 11 | 2021 | 38 | 3.170 |
Why?
|
| Early Detection of Cancer | 11 | 2021 | 336 | 2.900 |
Why?
|
| Papillomaviridae | 12 | 2023 | 127 | 2.880 |
Why?
|
| Papillomavirus Vaccines | 12 | 2021 | 151 | 2.430 |
Why?
|
| HIV Infections | 16 | 2023 | 2303 | 2.390 |
Why?
|
| Middle Aged | 71 | 2022 | 10129 | 2.200 |
Why?
|
| Young Adult | 50 | 2022 | 4268 | 2.100 |
Why?
|
| Periodontitis | 3 | 2022 | 53 | 2.020 |
Why?
|
| Adult | 70 | 2022 | 11712 | 1.950 |
Why?
|
| Female | 84 | 2023 | 20969 | 1.890 |
Why?
|
| Neoplasms | 13 | 2024 | 1103 | 1.800 |
Why?
|
| Cross-Sectional Studies | 31 | 2022 | 2721 | 1.790 |
Why?
|
| Humans | 106 | 2024 | 37093 | 1.740 |
Why?
|
| Vaginal Smears | 4 | 2015 | 57 | 1.710 |
Why?
|
| Cervix Uteri | 4 | 2017 | 42 | 1.540 |
Why?
|
| Incidence | 19 | 2021 | 922 | 1.520 |
Why?
|
| Adolescent | 31 | 2021 | 5363 | 1.440 |
Why?
|
| Risk Factors | 29 | 2023 | 3562 | 1.380 |
Why?
|
| Health Knowledge, Attitudes, Practice | 11 | 2021 | 864 | 1.380 |
Why?
|
| Mouth Neoplasms | 3 | 2018 | 71 | 1.360 |
Why?
|
| Prevalence | 20 | 2020 | 1455 | 1.300 |
Why?
|
| Vulvar Neoplasms | 2 | 2018 | 12 | 1.300 |
Why?
|
| Colorectal Neoplasms | 5 | 2016 | 441 | 1.270 |
Why?
|
| Male | 62 | 2023 | 20025 | 1.230 |
Why?
|
| Aged | 36 | 2020 | 6741 | 1.220 |
Why?
|
| Antibodies, Viral | 2 | 2018 | 262 | 1.070 |
Why?
|
| Registries | 8 | 2016 | 335 | 0.970 |
Why?
|
| Mass Screening | 3 | 2021 | 462 | 0.960 |
Why?
|
| Cyclonic Storms | 2 | 2021 | 64 | 0.920 |
Why?
|
| DNA, Viral | 5 | 2017 | 304 | 0.910 |
Why?
|
| Genotype | 6 | 2023 | 730 | 0.890 |
Why?
|
| Sexual Behavior | 7 | 2015 | 609 | 0.890 |
Why?
|
| Obesity | 9 | 2020 | 1067 | 0.860 |
Why?
|
| United States | 17 | 2024 | 4223 | 0.860 |
Why?
|
| Periodontal Diseases | 1 | 2022 | 49 | 0.830 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2021 | 178 | 0.820 |
Why?
|
| Pharyngeal Neoplasms | 2 | 2013 | 8 | 0.810 |
Why?
|
| Earthquakes | 1 | 2021 | 7 | 0.810 |
Why?
|
| Penile Neoplasms | 2 | 2018 | 14 | 0.760 |
Why?
|
| Body Mass Index | 5 | 2020 | 854 | 0.740 |
Why?
|
| Age Factors | 8 | 2018 | 1033 | 0.730 |
Why?
|
| Anal Canal | 3 | 2021 | 30 | 0.730 |
Why?
|
| Endoscopy | 1 | 2020 | 14 | 0.710 |
Why?
|
| Bibliometrics | 2 | 2010 | 17 | 0.710 |
Why?
|
| Biopsy | 2 | 2020 | 164 | 0.710 |
Why?
|
| Cytological Techniques | 1 | 2020 | 15 | 0.710 |
Why?
|
| Vaccination | 5 | 2021 | 288 | 0.700 |
Why?
|
| Chlamydia trachomatis | 1 | 2020 | 68 | 0.690 |
Why?
|
| Video Recording | 1 | 2019 | 32 | 0.670 |
Why?
|
| Anus Diseases | 2 | 2016 | 17 | 0.660 |
Why?
|
| Patient Compliance | 1 | 2020 | 212 | 0.630 |
Why?
|
| Odds Ratio | 6 | 2018 | 534 | 0.610 |
Why?
|
| Chlamydia Infections | 1 | 2020 | 196 | 0.610 |
Why?
|
| Biomedical Research | 4 | 2012 | 400 | 0.590 |
Why?
|
| Insurance, Health | 2 | 2016 | 126 | 0.570 |
Why?
|
| Health Planning | 1 | 2016 | 16 | 0.560 |
Why?
|
| Health Promotion | 3 | 2019 | 653 | 0.560 |
Why?
|
| Government Programs | 1 | 2016 | 29 | 0.560 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 28 | 0.550 |
Why?
|
| Models, Theoretical | 1 | 2017 | 217 | 0.540 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2017 | 215 | 0.540 |
Why?
|
| Logistic Models | 9 | 2018 | 923 | 0.540 |
Why?
|
| Risk-Taking | 4 | 2015 | 451 | 0.540 |
Why?
|
| Seroepidemiologic Studies | 5 | 2020 | 68 | 0.530 |
Why?
|
| Specimen Handling | 2 | 2013 | 56 | 0.520 |
Why?
|
| Stomatitis | 1 | 2014 | 2 | 0.510 |
Why?
|
| Cardiovascular Diseases | 4 | 2015 | 664 | 0.500 |
Why?
|
| Comorbidity | 6 | 2018 | 623 | 0.490 |
Why?
|
| Mouth | 1 | 2014 | 45 | 0.490 |
Why?
|
| HIV Seroprevalence | 1 | 2014 | 14 | 0.480 |
Why?
|
| Prediabetic State | 1 | 2015 | 53 | 0.480 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2021 | 404 | 0.480 |
Why?
|
| Gynecology | 1 | 2014 | 31 | 0.480 |
Why?
|
| Mouth Diseases | 1 | 2014 | 6 | 0.480 |
Why?
|
| Aged, 80 and over | 10 | 2018 | 2379 | 0.470 |
Why?
|
| Gastroenterology | 1 | 2013 | 7 | 0.470 |
Why?
|
| Obstetrics | 1 | 2014 | 37 | 0.470 |
Why?
|
| Medical Oncology | 1 | 2013 | 30 | 0.460 |
Why?
|
| Insurance Coverage | 1 | 2014 | 100 | 0.460 |
Why?
|
| Sex Factors | 6 | 2018 | 898 | 0.450 |
Why?
|
| Self Administration | 1 | 2013 | 42 | 0.440 |
Why?
|
| Receptor, erbB-2 | 2 | 2013 | 133 | 0.440 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 485 | 0.420 |
Why?
|
| Education, Medical | 1 | 2013 | 104 | 0.420 |
Why?
|
| Ambulatory Care | 1 | 2013 | 75 | 0.420 |
Why?
|
| Retrospective Studies | 8 | 2021 | 2026 | 0.420 |
Why?
|
| Endometrial Neoplasms | 2 | 2010 | 66 | 0.420 |
Why?
|
| Capacity Building | 1 | 2012 | 87 | 0.400 |
Why?
|
| Liver Neoplasms | 2 | 2011 | 190 | 0.400 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 30 | 0.400 |
Why?
|
| Liver Diseases | 1 | 2011 | 33 | 0.390 |
Why?
|
| Self Care | 1 | 2012 | 159 | 0.390 |
Why?
|
| Patient Selection | 1 | 2012 | 164 | 0.390 |
Why?
|
| Survival Analysis | 4 | 2018 | 325 | 0.390 |
Why?
|
| Uterine Neoplasms | 1 | 2012 | 39 | 0.390 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 204 | 0.380 |
Why?
|
| Sexually Transmitted Diseases | 4 | 2014 | 164 | 0.380 |
Why?
|
| Genetic Testing | 1 | 2011 | 75 | 0.380 |
Why?
|
| Diabetes Complications | 1 | 2011 | 90 | 0.380 |
Why?
|
| Menopause | 3 | 2010 | 56 | 0.370 |
Why?
|
| Breast Neoplasms | 2 | 2013 | 1502 | 0.370 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 312 | 0.370 |
Why?
|
| Adenoma | 1 | 2011 | 89 | 0.370 |
Why?
|
| Substance-Related Disorders | 2 | 2014 | 730 | 0.350 |
Why?
|
| Socioeconomic Factors | 7 | 2015 | 1067 | 0.350 |
Why?
|
| Insulin Resistance | 1 | 2011 | 184 | 0.340 |
Why?
|
| Vehicle Emissions | 1 | 2009 | 23 | 0.340 |
Why?
|
| Respiratory Tract Diseases | 1 | 2009 | 23 | 0.340 |
Why?
|
| Publishing | 1 | 2009 | 24 | 0.330 |
Why?
|
| Particulate Matter | 1 | 2009 | 51 | 0.330 |
Why?
|
| SEER Program | 4 | 2013 | 91 | 0.330 |
Why?
|
| Urban Population | 2 | 2010 | 333 | 0.330 |
Why?
|
| Multivariate Analysis | 4 | 2015 | 583 | 0.330 |
Why?
|
| Sexual Partners | 4 | 2017 | 314 | 0.310 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 448 | 0.300 |
Why?
|
| Minority Groups | 1 | 2012 | 596 | 0.300 |
Why?
|
| Homosexuality, Male | 3 | 2021 | 458 | 0.290 |
Why?
|
| Environmental Exposure | 1 | 2009 | 216 | 0.290 |
Why?
|
| Smoking | 3 | 2014 | 940 | 0.290 |
Why?
|
| Cost of Illness | 3 | 2017 | 76 | 0.280 |
Why?
|
| Prognosis | 4 | 2018 | 739 | 0.270 |
Why?
|
| Human papillomavirus 16 | 2 | 2018 | 35 | 0.270 |
Why?
|
| Nutrition Surveys | 2 | 2018 | 242 | 0.260 |
Why?
|
| Sex Distribution | 3 | 2014 | 215 | 0.250 |
Why?
|
| Proportional Hazards Models | 4 | 2018 | 441 | 0.250 |
Why?
|
| Survival Rate | 4 | 2014 | 311 | 0.240 |
Why?
|
| Inflammation | 2 | 2022 | 618 | 0.240 |
Why?
|
| Caribbean Region | 1 | 2024 | 69 | 0.240 |
Why?
|
| Child | 6 | 2021 | 3131 | 0.230 |
Why?
|
| Risk Assessment | 3 | 2018 | 753 | 0.230 |
Why?
|
| Disaster Planning | 1 | 2024 | 52 | 0.230 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 935 | 0.220 |
Why?
|
| Disasters | 1 | 2024 | 65 | 0.220 |
Why?
|
| Blood Glucose | 3 | 2015 | 353 | 0.210 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2015 | 92 | 0.210 |
Why?
|
| Sampling Studies | 2 | 2014 | 61 | 0.210 |
Why?
|
| Population Surveillance | 2 | 2015 | 238 | 0.210 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2021 | 1 | 0.210 |
Why?
|
| Meningococcal Vaccines | 1 | 2021 | 7 | 0.200 |
Why?
|
| Smoking Cessation | 1 | 2008 | 517 | 0.200 |
Why?
|
| Program Evaluation | 2 | 2021 | 339 | 0.190 |
Why?
|
| Age Distribution | 4 | 2014 | 225 | 0.190 |
Why?
|
| Healthcare Disparities | 2 | 2018 | 494 | 0.190 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 400 | 0.190 |
Why?
|
| Databases, Factual | 1 | 2021 | 291 | 0.180 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 562 | 0.180 |
Why?
|
| Unsafe Sex | 2 | 2012 | 161 | 0.180 |
Why?
|
| Medicaid | 1 | 2021 | 109 | 0.180 |
Why?
|
| Urban Health | 2 | 2018 | 95 | 0.180 |
Why?
|
| Schools | 4 | 2021 | 260 | 0.170 |
Why?
|
| Women's Health | 2 | 2010 | 145 | 0.170 |
Why?
|
| Histocytochemistry | 1 | 2018 | 50 | 0.160 |
Why?
|
| Neoplasm Staging | 2 | 2016 | 275 | 0.160 |
Why?
|
| Human papillomavirus 6 | 1 | 2018 | 1 | 0.160 |
Why?
|
| Human papillomavirus 11 | 1 | 2018 | 2 | 0.160 |
Why?
|
| Human papillomavirus 18 | 1 | 2018 | 5 | 0.160 |
Why?
|
| Risk | 4 | 2013 | 267 | 0.150 |
Why?
|
| Data Collection | 2 | 2015 | 194 | 0.150 |
Why?
|
| Hepatitis C | 2 | 2010 | 125 | 0.150 |
Why?
|
| Feeding Behavior | 2 | 2013 | 454 | 0.150 |
Why?
|
| Condylomata Acuminata | 1 | 2017 | 6 | 0.150 |
Why?
|
| Feasibility Studies | 2 | 2015 | 208 | 0.140 |
Why?
|
| Confidence Intervals | 2 | 2013 | 149 | 0.140 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2016 | 9 | 0.140 |
Why?
|
| Students | 1 | 2021 | 519 | 0.140 |
Why?
|
| Pregnancy | 3 | 2018 | 1549 | 0.140 |
Why?
|
| Penile Diseases | 1 | 2015 | 7 | 0.130 |
Why?
|
| Life Style | 4 | 2010 | 308 | 0.130 |
Why?
|
| Guideline Adherence | 2 | 2013 | 84 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 1 | 2016 | 78 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 885 | 0.130 |
Why?
|
| Waist-Hip Ratio | 2 | 2011 | 34 | 0.120 |
Why?
|
| Interviews as Topic | 1 | 2016 | 381 | 0.120 |
Why?
|
| Adipokines | 1 | 2014 | 24 | 0.120 |
Why?
|
| Overweight | 2 | 2014 | 247 | 0.120 |
Why?
|
| Sentinel Surveillance | 1 | 2014 | 21 | 0.120 |
Why?
|
| Palatal Neoplasms | 1 | 2013 | 3 | 0.120 |
Why?
|
| Tonsillar Neoplasms | 1 | 2013 | 3 | 0.120 |
Why?
|
| Health Care Reform | 1 | 2014 | 32 | 0.120 |
Why?
|
| Warts | 1 | 2013 | 5 | 0.120 |
Why?
|
| Health Personnel | 1 | 2016 | 228 | 0.120 |
Why?
|
| Tongue Neoplasms | 1 | 2013 | 11 | 0.120 |
Why?
|
| Education, Medical, Continuing | 1 | 2013 | 32 | 0.120 |
Why?
|
| Time Factors | 3 | 2014 | 1742 | 0.110 |
Why?
|
| Uterine Cervical Diseases | 1 | 2013 | 14 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2013 | 86 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 217 | 0.110 |
Why?
|
| Prisoners | 1 | 2014 | 83 | 0.110 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 113 | 0.110 |
Why?
|
| HIV Seropositivity | 1 | 2014 | 190 | 0.110 |
Why?
|
| Syphilis | 1 | 2013 | 23 | 0.110 |
Why?
|
| Receptors, Progesterone | 1 | 2013 | 81 | 0.110 |
Why?
|
| Cluster Analysis | 2 | 2012 | 195 | 0.110 |
Why?
|
| Medicare | 1 | 2014 | 195 | 0.110 |
Why?
|
| Vegetables | 1 | 2013 | 147 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2013 | 125 | 0.100 |
Why?
|
| Fruit | 1 | 2013 | 173 | 0.100 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 156 | 0.100 |
Why?
|
| Health Status Disparities | 2 | 2024 | 642 | 0.100 |
Why?
|
| Libido | 2 | 2009 | 6 | 0.100 |
Why?
|
| Students, Medical | 1 | 2013 | 130 | 0.100 |
Why?
|
| Probability | 1 | 2012 | 78 | 0.100 |
Why?
|
| Medically Underserved Area | 1 | 2012 | 104 | 0.100 |
Why?
|
| Hepatitis B Vaccines | 1 | 2011 | 14 | 0.100 |
Why?
|
| Alcoholism | 1 | 2014 | 240 | 0.100 |
Why?
|
| Physicians | 1 | 2013 | 163 | 0.100 |
Why?
|
| Biotechnology | 1 | 2011 | 15 | 0.100 |
Why?
|
| Coitus | 1 | 2011 | 13 | 0.100 |
Why?
|
| Hepatitis B | 1 | 2011 | 38 | 0.100 |
Why?
|
| Consumer Health Information | 1 | 2011 | 22 | 0.100 |
Why?
|
| Marketing | 1 | 2011 | 40 | 0.100 |
Why?
|
| Esophageal Neoplasms | 1 | 2012 | 127 | 0.100 |
Why?
|
| Databases, Bibliographic | 1 | 2010 | 9 | 0.090 |
Why?
|
| Efficiency | 1 | 2010 | 16 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 807 | 0.090 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2010 | 12 | 0.090 |
Why?
|
| Herpes Simplex | 1 | 2010 | 16 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2014 | 1369 | 0.090 |
Why?
|
| Quality of Life | 1 | 2014 | 481 | 0.090 |
Why?
|
| Calcium, Dietary | 1 | 2010 | 85 | 0.090 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2011 | 155 | 0.090 |
Why?
|
| Diabetes, Gestational | 1 | 2010 | 47 | 0.090 |
Why?
|
| Adiposity | 1 | 2011 | 154 | 0.090 |
Why?
|
| Dyspareunia | 1 | 2009 | 2 | 0.090 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 215 | 0.090 |
Why?
|
| Urinary Incontinence | 1 | 2009 | 15 | 0.090 |
Why?
|
| Nausea | 1 | 2009 | 11 | 0.090 |
Why?
|
| Vomiting | 1 | 2009 | 14 | 0.090 |
Why?
|
| Information Seeking Behavior | 1 | 2010 | 26 | 0.090 |
Why?
|
| Health Behavior | 1 | 2013 | 537 | 0.090 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 560 | 0.090 |
Why?
|
| Kidney Diseases | 1 | 2011 | 167 | 0.080 |
Why?
|
| Employment | 2 | 2009 | 76 | 0.080 |
Why?
|
| Minerals | 1 | 2009 | 47 | 0.080 |
Why?
|
| Dust | 1 | 2009 | 54 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2010 | 208 | 0.080 |
Why?
|
| Disease Progression | 1 | 2011 | 601 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2014 | 583 | 0.080 |
Why?
|
| Vulnerable Populations | 2 | 2024 | 140 | 0.080 |
Why?
|
| Health Surveys | 1 | 2010 | 373 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2011 | 484 | 0.080 |
Why?
|
| Health Education | 1 | 2011 | 338 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2009 | 145 | 0.070 |
Why?
|
| Parity | 1 | 2006 | 46 | 0.070 |
Why?
|
| Ovariectomy | 1 | 2006 | 105 | 0.070 |
Why?
|
| Ambulatory Care Facilities | 2 | 2018 | 61 | 0.070 |
Why?
|
| Internet | 2 | 2021 | 211 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2006 | 104 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2006 | 455 | 0.060 |
Why?
|
| Educational Status | 3 | 2010 | 313 | 0.060 |
Why?
|
| Public Health | 1 | 2007 | 372 | 0.060 |
Why?
|
| Communication | 1 | 2024 | 180 | 0.050 |
Why?
|
| Community-Institutional Relations | 1 | 2024 | 187 | 0.050 |
Why?
|
| Hypertension | 2 | 2008 | 796 | 0.050 |
Why?
|
| Immunization Schedule | 1 | 2021 | 7 | 0.050 |
Why?
|
| Depression | 1 | 2008 | 712 | 0.050 |
Why?
|
| Blood Pressure | 2 | 2014 | 646 | 0.040 |
Why?
|
| Colposcopy | 1 | 2018 | 13 | 0.040 |
Why?
|
| Parents | 1 | 2021 | 329 | 0.040 |
Why?
|
| Universities | 1 | 2021 | 442 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2016 | 29 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 306 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 623 | 0.030 |
Why?
|
| DNA Probes, HPV | 1 | 2013 | 3 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 54 | 0.030 |
Why?
|
| Morbidity | 1 | 2013 | 91 | 0.030 |
Why?
|
| Health Facilities | 1 | 2013 | 27 | 0.030 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2012 | 8 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2012 | 49 | 0.030 |
Why?
|
| Culture | 1 | 2013 | 173 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 626 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 251 | 0.030 |
Why?
|
| Complement C4 | 1 | 2011 | 5 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 974 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2011 | 23 | 0.020 |
Why?
|
| Proteinuria | 1 | 2011 | 50 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2011 | 39 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2011 | 68 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2011 | 97 | 0.020 |
Why?
|
| Body Height | 1 | 2011 | 53 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2011 | 89 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2011 | 139 | 0.020 |
Why?
|
| Diet Records | 1 | 2010 | 60 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2011 | 127 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 149 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2011 | 146 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2010 | 104 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 661 | 0.020 |
Why?
|
| Schools, Medical | 1 | 2012 | 198 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2010 | 45 | 0.020 |
Why?
|
| Vaginal Diseases | 1 | 2009 | 9 | 0.020 |
Why?
|
| Hepatectomy | 1 | 2009 | 5 | 0.020 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2009 | 44 | 0.020 |
Why?
|
| Spouses | 1 | 2009 | 30 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 108 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 148 | 0.020 |
Why?
|
| Linear Models | 1 | 2009 | 275 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2011 | 325 | 0.020 |
Why?
|
| Trust | 1 | 2010 | 133 | 0.020 |
Why?
|
| Hepatitis C Antibodies | 1 | 2007 | 10 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2008 | 36 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 610 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1130 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2010 | 446 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2011 | 1492 | 0.020 |
Why?
|
| Health Status | 1 | 2009 | 380 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2010 | 519 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 803 | 0.010 |
Why?
|